Format

Send to

Choose Destination
Ophthalmology. 1999 Oct;106(10):1984-9.

Treatment of persistent corneal epithelial defect by autologous serum application.

Author information

1
Department of Ophthalmology and Oral Health Center, Tokyo Dental College, Ichikawa-shi, Chiba, Japan. kazuo@eyebank.or.jp

Abstract

OBJECTIVE:

To evaluate the efficacy of autologous serum application for the treatment of persistent epithelial defect.

DESIGN:

Prospective, clinical, noncomparative case series.

PARTICIPANTS:

A total of 16 eyes were studied.

INTERVENTION:

Autologous serum was prepared from the patients and diluted to 20% by saline. The patients were instructed to use the autologous serum six to ten times a day. The concentration of vitamin A, epidermal growth factor (EGF), and transforming growth factor-beta (TGF-beta) was measured at 1 week and 1 month stored in the refrigerator and 1 month and 3 months in the freezer.

MAIN OUTCOME MEASURES:

Time to closure of epithelial defect.

RESULTS:

Vitamin A, EGF, and TGF-beta were stable during the 1 month in the refrigerator and 3 months in the freezer. Among 16 persistent epithelial defects, 7 (43.8%) healed within 2 weeks, 3 (18.8%) healed within 1 month, and the remaining 6 (37.5%) did not respond within 1 month. No apparent side effect of autologous serum application was observed.

CONCLUSIONS:

Autologous serum application healed 43.8% of persistent defect within 2 weeks and 62.5% within 1 month.

PMID:
10519596
DOI:
10.1016/S0161-6420(99)90412-8
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center